Daniil Gataulin
Stock Analyst at Chardan Capital
(4.78)
# 112
Out of 5,127 analysts
119
Total ratings
62.39%
Success rate
41.99%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RGNX REGENXBIO | Maintains: Buy | $52 | $10.31 | +404.36% | 15 | Jan 29, 2026 | |
| OCGN Ocugen | Maintains: Buy | $7 | $1.38 | +407.25% | 15 | Jan 20, 2026 | |
| OTLK Outlook Therapeutics | Maintains: Neutral | $3 → $1 | $0.40 | +147.16% | 11 | Jan 5, 2026 | |
| ANNX Annexon | Initiates: Buy | $16 | $5.63 | +184.19% | 1 | Dec 23, 2025 | |
| KLRS Kalaris Therapeutics | Initiates: Buy | $19 | $9.05 | +109.94% | 1 | Dec 23, 2025 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $21 | $9.43 | +122.69% | 4 | Dec 9, 2025 | |
| QURE uniQure | Maintains: Buy | $53 | $26.05 | +103.45% | 11 | Dec 4, 2025 | |
| FBRX Forte Biosciences | Maintains: Buy | $61 | $29.81 | +104.63% | 7 | Nov 17, 2025 | |
| KOD Kodiak Sciences | Maintains: Neutral | $14 | $24.30 | -42.39% | 4 | Nov 17, 2025 | |
| ZURA Zura Bio | Maintains: Buy | $10 | $6.27 | +59.49% | 3 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 | $7.63 | +358.72% | 7 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 | $3.38 | +166.27% | 3 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 | $28.35 | +79.89% | 9 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 | $5.50 | +172.73% | 7 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $1.07 | +273.83% | 8 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 | $14.07 | +91.90% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $0.59 | +37,378.71% | 1 | Mar 7, 2024 |
REGENXBIO
Jan 29, 2026
Maintains: Buy
Price Target: $52
Current: $10.31
Upside: +404.36%
Ocugen
Jan 20, 2026
Maintains: Buy
Price Target: $7
Current: $1.38
Upside: +407.25%
Outlook Therapeutics
Jan 5, 2026
Maintains: Neutral
Price Target: $3 → $1
Current: $0.40
Upside: +147.16%
Annexon
Dec 23, 2025
Initiates: Buy
Price Target: $16
Current: $5.63
Upside: +184.19%
Kalaris Therapeutics
Dec 23, 2025
Initiates: Buy
Price Target: $19
Current: $9.05
Upside: +109.94%
Ocular Therapeutix
Dec 9, 2025
Maintains: Buy
Price Target: $21
Current: $9.43
Upside: +122.69%
uniQure
Dec 4, 2025
Maintains: Buy
Price Target: $53
Current: $26.05
Upside: +103.45%
Forte Biosciences
Nov 17, 2025
Maintains: Buy
Price Target: $61
Current: $29.81
Upside: +104.63%
Kodiak Sciences
Nov 17, 2025
Maintains: Neutral
Price Target: $14
Current: $24.30
Upside: -42.39%
Zura Bio
Nov 14, 2025
Maintains: Buy
Price Target: $10
Current: $6.27
Upside: +59.49%
Nov 14, 2025
Maintains: Buy
Price Target: $35
Current: $7.63
Upside: +358.72%
Nov 13, 2025
Maintains: Buy
Price Target: $9
Current: $3.38
Upside: +166.27%
Nov 11, 2025
Maintains: Buy
Price Target: $51
Current: $28.35
Upside: +79.89%
Aug 11, 2025
Maintains: Buy
Price Target: $15
Current: $5.50
Upside: +172.73%
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $1.07
Upside: +273.83%
Aug 7, 2025
Maintains: Buy
Price Target: $27
Current: $14.07
Upside: +91.90%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $0.59
Upside: +37,378.71%